Phase II Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas
Latest Information Update: 15 Dec 2023
At a glance
- Drugs Trabectedin (Primary) ; Dexamethasone; Dexamethasone; Ondansetron
- Indications Chondrosarcoma; Ewing's sarcoma; Osteosarcoma; Rhabdomyosarcoma; Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms SYNERGIAS
- 24 Oct 2023 Results (n=33; From June/2021 to March/2023) assessing the QoL improvement and safety of Trabectedin plus radiotherapy on symptomatic advanced sarcoma patients, presented at the 48th European Society for Medical Oncology Congress.
- 24 Nov 2021 New trial record